131 related articles for article (PubMed ID: 29430849)
1. MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.
Gu L; Sang M; Yin D; Liu F; Wu Y; Liu S; Huang W; Shan B
Thorac Cancer; 2018 Apr; 9(4):431-438. PubMed ID: 29430849
[TBL] [Abstract][Full Text] [Related]
2. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
4. Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group.
Myšíková D; Adkins I; Hradilová N; Palata O; Šimonek J; Pozniak J; Kolařík J; Skallová-Fialová A; Špíšek R; Lischke R
J Thorac Oncol; 2017 Feb; 12(2):249-257. PubMed ID: 27793776
[TBL] [Abstract][Full Text] [Related]
5. Melanoma-associated antigen genes: a new trend to predict the prognosis of breast cancer patients.
Abd-Elsalam EA; Ismaeil NA
Med Oncol; 2014 Nov; 31(11):285. PubMed ID: 25316266
[TBL] [Abstract][Full Text] [Related]
6. [Detection rate of MAGE-A1-A6 mRNA in the peripheral blood of cancer patients].
Novikov DV; Belova TV; Pegov RG; Aliasova AA; Morozova PN; Kniazev DI; Kalugin AV; Kontorshchikova KN; Baryshnikov AIu; Novikov VV
Klin Lab Diagn; 2009 Apr; (4):25-7. PubMed ID: 19514330
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer.
Ujiie H; Kato T; Lee D; Hu HP; Fujino K; Kaji M; Kaga K; Matsui Y; Yasufuku K
Int J Oncol; 2017 Jun; 50(6):2154-2170. PubMed ID: 28498455
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy.
Shin KC; Choi EY; Chung JH; Jeon C; Lee KH
Anticancer Res; 2012 Jan; 32(1):163-7. PubMed ID: 22213302
[TBL] [Abstract][Full Text] [Related]
9. Multiple MAGE-A genes as surveillance marker for the detection of circulating tumor cells in patients with ovarian cancer.
Sang M; Wu X; Fan X; Sang M; Zhou X; Zhou N
Biomarkers; 2014 Feb; 19(1):34-42. PubMed ID: 24320162
[TBL] [Abstract][Full Text] [Related]
10. Characterization of melanoma-associated antigen-a genes family differential expression in non-small-cell lung cancers.
Karimi S; Mohammadi F; Porabdollah M; Mohajerani SA; Khodadad K; Nadji SA
Clin Lung Cancer; 2012 May; 13(3):214-9. PubMed ID: 22138038
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of MAGE genes in human lung cancer].
Li G; Song P; Zhang B
Zhongguo Fei Ai Za Zhi; 2013 Jun; 16(6):308-13. PubMed ID: 23769346
[TBL] [Abstract][Full Text] [Related]
12. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
[TBL] [Abstract][Full Text] [Related]
13. A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non-Small Cell Lung Cancer.
Mecklenburg I; Sienel W; Schmid S; Passlick B; Kufer P
Clin Cancer Res; 2017 Mar; 23(5):1213-1219. PubMed ID: 27542766
[No Abstract] [Full Text] [Related]
14. [Detection of tumor cells in peripheral blood of patients with gastric cancer using mRNA of MAGE genes as markers].
Wang WX; Li YB; Xie XL; Shu XL; Ouyang XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):611-4. PubMed ID: 19921576
[TBL] [Abstract][Full Text] [Related]
15. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
17. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.
Zhang S; Zhai X; Wang G; Feng J; Zhu H; Xu L; Mao G; Huang J
Int J Clin Exp Pathol; 2015; 8(1):541-50. PubMed ID: 25755744
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas.
Li X; Hughes SC; Wevrick R
Cancer Genet; 2015; 208(1-2):25-34. PubMed ID: 25592766
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
[TBL] [Abstract][Full Text] [Related]
20. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
